Syndax Pharmaceuticals Inc Human Resources Contracts & Agreements
41 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Compensation Agreements (3)
- Consulting Agreements (1)
- Employment Agreements (29)
- Employment Agreement, dated March 18, 2024, by and between the Company and Steven Closter (Filed With SEC on March 18, 2024)
- Non-employee Director Compensation Policy, as amended, dated as of February 7, 2024 (Filed With SEC on February 27, 2024)
- Amendment to Executive Employment by and between the Company and Neil Gallagher, M.D., Ph.D., dated as of February 26, 2024 (Filed With SEC on February 27, 2024)
- Amendment to Executive Employment by and between the Company and Keith A. Goldan, dated as of February 26, 2024 (Filed With SEC on February 27, 2024)
- Amendment to Executive Employment by and between the Company and Catherine Madigan, M.D., dated as of February 26, 2024 (Filed With SEC on February 27, 2024)
- Amendment to Amended and Restated Executive Employment by and between the Company and Luke J. Albrecht, dated as of February 26, 2024 (Filed With SEC on February 27, 2024)
- Amended and Restated Executive Employment Agreement by and between the Company and Luke J. Albrecht, dated as of April 27, 2020 (Filed With SEC on February 27, 2024)
- Amendment to Amended and Restated Executive Employment by and between the Company and Michael A. Metzger, dated as of February 26, 2024 (Filed With SEC on February 27, 2024)
- Employment Agreement, dated December 1, 2022, by and between the Company and Steve Sabus (Filed With SEC on December 5, 2022)
- Employment Agreement, dated June 8, 2022, by and between the Company and Keith A. Goldan (Filed With SEC on June 13, 2022)
- Executive Employment Agreement by and between the Company and Anjali Ganguli, Ph.D., dated as of September 30, 2021 (Filed With SEC on May 9, 2022)
- Executive Employment Agreement by and between the Company and Catherine Madigan, M.D., dated as of March 1, 2022 (Filed With SEC on May 9, 2022)
- Non-employee Director Compensation Policy, as amended, dated as of February 2, 2022 (Filed With SEC on March 1, 2022)
- Amended and Restated Executive Employment Agreement by and between the Company and Michael A. Metzger, dated as of February 2, 2022 (Filed With SEC on March 1, 2022)
- Amended and Restated Executive Employment Agreement by and between the Company and Briggs W. Morrison, M.D., dated as of February 2, 2022 (Filed With SEC on March 1, 2022)
- Amended and Restated Employment Agreement, dated February 2, 2022, by and between the Company and Michael A. Metzger (Filed With SEC on February 3, 2022)
- Amended and Restated Employment Agreement, dated February 2, 2022, by and between the Company and Briggs W. Morrison, M.D (Filed With SEC on February 3, 2022)
- Form of Deferred Settlement Stock Unit Agreement under 2015 Omnibus Incentive Plan (Filed With SEC on March 12, 2021)
- Executive Employment Agreement by and between the Company and Daphne Karydas, dated as of July 6, 2020 (Filed With SEC on November 5, 2020)
- Form of Stock Unit Agreement under 2015 Omnibus Incentive Plan (Filed With SEC on August 6, 2020)
- Amended and Restated Executive Employment Agreement by and between the Company and Richard P. Shea, dated as of April 27, 2020 (Filed With SEC on May 7, 2020)
- Amended and Restated Executive Employment Agreement by and between the Company and Michael L. Meyers, M.D., Ph.D., dated as of April 27, 2020 (Filed With SEC on May 7, 2020)
- Amended and Restated Executive Employment Agreement by and between the Company and Michael A. Metzger, dated as of April 27, 2020 (Filed With SEC on May 7, 2020)
- Amended and Restated Executive Employment Agreement by and between the Company and Briggs W. Morrison, M.D., dated as of April 27, 2020 (Filed With SEC on May 7, 2020)
- Non-employee Director Compensation Policy, as amended, February 12, 2020 (Filed With SEC on May 7, 2020)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 22, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 10, 2016)
- GENERAL RELEASE AND POST-SEPARATION CONSULTING AGREEMENT (Filed With SEC on January 4, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 4, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 4, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 4, 2016)
- SYNDAX PHARMACEUTICALS, INC. 2015 OMNIBUS INCENTIVE PLAN NON-QUALIFIED OPTION AGREEMENT (Filed With SEC on January 4, 2016)
- SYNDAX PHARMACEUTICALS, INC. 2015 OMNIBUS INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on January 4, 2016)
- SYNDAX PHARMACEUTICALS, INC. 2015 OMNIBUS INCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on January 4, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 27, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 27, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 27, 2014)
- SYNDAX PHARMACEUTICALS, INC. 2013 OMNIBUS INCENTIVE PLAN NON-QUALIFIED OPTION AGREEMENT (Filed With SEC on March 27, 2014)
- SYNDAX PHARMACEUTICALS, INC. 2013 OMNIBUS INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on March 27, 2014)
